Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Alaunos Therapeutics, Inc. (TCRT) had Normalized Income after Taxes of $-0.95M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-0.95M |
|
-- |
|
-- |
|
$0.95M |
|
$-0.95M |
|
-- |
|
$-0.95M |
|
$-0.95M |
|
$-0.95M |
|
$-0.95M |
|
$-0.95M |
|
|
Normalized Income after Taxes |
$-0.95M |
$-0.95M |
|
$-0.94M |
|
2.43M |
|
2.43M |
|
$-0.41 |
|
$-0.41 |
|
| Balance Sheet Financials | |
$0.67M |
|
$0.07M |
|
$0.85M |
|
$1.52M |
|
$0.86M |
|
-- |
|
-- |
|
$0.86M |
|
$0.65M |
|
$0.65M |
|
$0.65M |
|
2.49M |
|
| Cash Flow Statement Financials | |
$-1.33M |
|
$0.00M |
|
$0.07M |
|
$1.39M |
|
$0.12M |
|
$-1.26M |
|
$0.11M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.77 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.33M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-146.02% |
|
-146.01% |
|
-62.80% |
|
-146.01% |
|
$0.26 |
|
$-0.55 |
|
$-0.55 |
|